Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Trinity Life Sciences introduces new customer engagement solutions, leveraging its deep commercial insight and renowned technology platform

leveraging both Trinity’s deep commercial insight and recognized technology platform. The new offerings are designed to help life sciences organizations with novel customer engagement solutions including adaptive segmentation, rep-directed guidance...

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

at night,” said Carol Roberts, President, The PBCers Organization. “The availability of a new treatment option that can help reduce this intense itching while also improving biomarkers of active liver disease is a milestone for our community.” PBC...

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

to innovation, advocacy, and expertise to serve pharmacy customers with: XiFin’s award-winning Revenue Cycle Management to help enterprise pharmacies better manage the complexity of medical billing. New services such as CareALERTS™ designed to put...

Aptar’s Nasal Unidose System will deliver neffy® (epinephrine nasal spray), the first FDA-approved needle-free treatment for Type I allergic reactions, including anaphylaxis

than 30 years. We are proud of our role in the pharma industry to increase the use of nasally delivered medications that help promote adherence and ease of use for patients.” Unidose (UDS) and Bidose (BDS) Technology Platforms: Aptar’s UDS and BDS...

Bavarian Nordic gets a HERA order and announces a major vaccine donation for the Mpox outbreak in Africa

We also applaud the initiatives from the Africa CDC and WHO to strengthen and coordinate the public health response, helping to ensure our vaccine can reach more people on the African continent,” said Paul Chaplin, President and Chief Executive...

Stay Protected

infectious diseases at every stage of life. According to the Centers for Disease Control and Prevention (CDC), vaccines help create protective antibodies that fight infections. The experts at the CDC state childhood vaccinations, such as MMR...

Sensitech acquires Berlinger & Co. to expand life sciences cold chain solutions

About Sensitech: Sensitech® is a world leader in supply chain visibility. Our innovative monitoring products and services help to maintain the quality and integrity of our customers' valuable products at every step in their journey, all around the...

Jade Biosciences launches with $80 million to develop transformative autoimmune disease therapies

for patients living with autoimmune diseases," said Dr. King. "The company is backed by a strong slate of investors who helped fund the company and support its vision of delivering transformative therapies to patients in need." Jade is the fourth...

Eximia Research Network expands into Virginia by integrating Tidewater Clinical Research

of a team of industry professionals were key factors in our decision to join Eximia. Leveraging Eximia's resources will help us better serve our biotech and pharmaceutical clients and expand our services beyond dermatology," he concludes. Eximia...

Galderma’s Relfydess™ (RelabotulinumtoxinA) receives positive decision for use in Europe

and crow’s feet.3,4,7,8 It is optimized for simple volumetric dosing, without reconstitution, to increase ease of use and help ensure consistent dose/volume. About RelfydessTM (RelabotulinumtoxinA): Pioneered by Galderma, RelfydessTM is the first...

Teva and Sanofi Announce Accelerated Anti-TL1A Phase 2b Program for Inflammatory Bowel Disease

its 37,000 employees across 58 markets to push the boundaries of scientific innovation and deliver quality medicines to help improve health outcomes of millions of patients every day. For more information please visit www.tevapharm.com.

ViroCell Biologics Signs Master Services Agreement With Prominent NCI-Designated Cancer Center

become the partner of choice for companies developing cell and gene therapies. The team leverages its deep track record to help clients to de-risk and accelerate novel cell and gene therapies into and through clinical development, with a mission of...

SHINE Technologies Showcases FLARE™, the World's Most Powerful Continuous Fusion Neutron System

or single-event, high-energy disturbances. These defense and satellite systems require radiation effects testing to help lessen those risks by examining the reliability of their components before they are deployed in missions. FLARE can complete...

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

living with chorea associated with Huntington's disease will experience swallowing issues," said Katie Jackson, President, Help 4 HD International. "The availability of a treatment for chorea that can be easily sprinkled onto food is very helpful...

Cytonics Begins First-In-Human Phase 1 Clinical Study for CYT-108 in Osteoarthritis Knee Patients

osteoarthritis. The company's flagship product was a diagnostic test (the Fibronectin-Aggrecan Complex Test, FACT) which helps identify the source of joint pain and assists physicians in determining the most appropriate course of treatment....

Genentech to Reintroduce Susvimo for Wet Age-related Macular Degeneration (AMD) Treatment

now meet these performance standards. Manufacturing process improvements were also implemented. Genentech is committed to helping people access the medicines they are prescribed and offers comprehensive services for people prescribed Susvimo to...

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

from patients with FL and DLBCL. The optimization part evaluates the potential for alternative step-up dosing regimens to help further minimize Grade 2 cytokine release syndrome (CRS) and mitigate Grade ≥3 CRS. The primary endpoint of the expansion...

Indivior Publishes New Data Comparing Effectiveness of Intranasal Nalmefene (OPVEE 2.7mg) and IN Naloxone (4mg) in Synthetic Opioid Overdose Model

rapidly with fentanyl and other synthetic opioids." About Indivior: Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat substance use disorders (SUD), opioid overdose and serious...

MTF Biologics and Centurion Therapeutics Partner to Expand Access to Advanced Wound Care Technologies

five years with us and demonstrated their reach within complex surgical wound care. The company is the ideal partner to help us deliver our innovative tissue solutions to healthcare professionals and, ultimately, save and heal more lives. We have...

Qosina Introduces New iDOT™ Single-Use Sensor Bag Ports from Polestar Technologies

along with its high service levels, extensive product portfolio, sampling capabilities and technical expertise, will help fill an important supply chain and distribution role for Polestar Technologies. Qosina is a one-stop source for single-use...